Adam Koppel
CIK 1578965 · EVP, Strategy and Bus. Dev. · last filed 2026-04-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$110.69M
Companies
11
Total Filings
64
Lifetime Open-Market Net
$112.76M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KLRA | Director | 22,583,268 | — | — | $25.00M | 1 | 2026-04-20 |
| FHTX | Director | — | $4.18 | — | $0 | 4 | 2024-06-28 |
| Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Director | 65,693,524 | $44.96 | $2.95B | $125.00M | 4 | 2024-06-07 |
| SLDB | Director | 4,034,582 | $7.14 | $28.81M | $4.80M | 13 | 2024-01-12 |
| Aptinyx Inc. (APTX) Delisted | Director | 5,558,425 | $0.06 | $339.1K | $16.40M | 10 | 2022-05-31 |
| Dicerna Pharmaceuticals Inc (DRNA) Delisted | Director | 0 | $38.22 | $0 | -$180.42M | 10 | 2021-12-29 |
| Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | Director | 60,632,356 | $18.07 | $1.10B | $103.42M | 3 | 2021-06-14 |
| BCLS Acquisition Corp. (BLSA) Delisted | Director | 487,500 | $10.04 | $4.89M | $0 | 1 | 2020-10-26 |
| TRVN | Director | — | $0.01 | — | $0 | 5 | 2018-05-17 |
| PTCT | Director | 1,083,333 | $75.14 | $81.40M | $18.75M | 5 | 2017-01-05 |
| BIIB | EVP, Strategy and Bus. Dev. | 2,402 | $200.05 | $480.5K | -$189.0K | 7 | 2016-06-07 |
Recent Filings · Page 3 of 7
64 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-25 | SLDB | Grant (A) | +869,565 | $5.00M | EDGAR |
| 2021-01-05 | Aptinyx Inc. (APTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-14 | Dicerna Pharmaceuticals Inc (DRNA) Delisted | Sell (S) | −1,000,000 | -$23.40M | EDGAR |
| 2020-12-11 | SLDB | Grant (A) | +3,189,189 | $11.80M | EDGAR |
| 2020-11-12 | Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | Buy (P) | +332,293 | $3.42M | EDGAR |
| 2020-10-29 | Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | Mixed | +59,961,943 | $100.00M | EDGAR |
| 2020-10-26 | BCLS Acquisition Corp. (BLSA) Delisted | Grant (A) | +487,500 | $4.88M | EDGAR |
| 2020-10-02 | Aptinyx Inc. (APTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-02 | Aptinyx Inc. (APTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-06-18 | SLDB | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.